WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops targeted anticancer products, today announced two senior management promotions. Daniel M. Junius has been named President and Chief Operating Officer. John M. Lambert, Ph.D., has been named Executive Vice President, Research and Development, and will continue as ImmunoGen’s Chief Scientific Officer.
